Gara Jalqabaatti › Sirna Itti-Fageenyaa fi Haala Itti › Oregon › Portland
Qorannoo klinikaalii Sirna Itti-Fageenyaa fi Haala Itti Portland, OR keessatti
Qorannoo 9 Sirna Itti-Fageenyaa fi Haala Itti f Portland fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Namoota walitti qabaa jiraSadarkaa 1
- Oregon Health & Science University, Portland
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Namoota walitti qabaa jiraSadarkaa 3
- Oregon Health & Science University, Portland
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Namoota walitti qabaa jiraQorannoo ilaalaa
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Portland VA Medical Center, Portland
- fi 1 dabalataa
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Namoota walitti qabaa jiraSadarkaa 3
- Oregon Health & Science University, Portland
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 1
- Providence Portland Medical Center, Portland
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Namoota walitti qabaa jiraSadarkaa 2
- Inmagene Site 3, Portland
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Namoota walitti qabaa jiraSadarkaa 2
- Oregon Health and Science University, Portland
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Namoota walitti qabaa jiraSadarkaa 1/2
- Providence Neurological Specialties West, Portland
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
Namoota walitti qabaa jiraSadarkaa 2
- Oregon Health and Science University, Portland
Qorannoo Sirna Itti-Fageenyaa fi Haala Itti magaalota biroo keessatti
- Washington, DCQorannoo 13
- New York City, NYQorannoo 12
- Boston, MAQorannoo 10
- Philadelphia, PAQorannoo 10
- Atlanta, GAQorannoo 9
- Houston, TXQorannoo 9
- Chicago, ILQorannoo 8
- Los Angeles, CAQorannoo 8
- Cleveland, OHQorannoo 8
- Seattle, WAQorannoo 6
- Cedar Rapids, IAQorannoo 6
- Milwaukee, WIQorannoo 6
Qorannoo biroo Portland keessatti
- Kansara Qara'a Non-Small CellQorannoo 46
- Saree (Gosoota Hunda)Qorannoo 34
- Kansarii ProstateQorannoo 33
- Saree OljooQorannoo 33
- Kansara MetastatikiiQorannoo 29
- Kansarii ColorectalQorannoo 28
- Kansarii OvariiQorannoo 27
- Dhibee QaraQorannoo 26
- Leukemia Myeloidii HamaaQorannoo 25
- Kansa EndometiriyaaliiQorannoo 24
- Kansa Selii Skwaamoo Mataa fi MormaQorannoo 19
- Kansarii PancreasQorannoo 19
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.